Printer Friendly

COMPANY INFORMATION
Biovail Corporation 7150 Mississauga Rd Mississauga, ON L5N 8M5 Tel: (905) 286-3000 Toll-free: (888) 214-6000 Fax: (905) 286-3050 Contact Name Nelson F. Isabel Industry Pharmaceuticals		Key Executives William M. Wells, CEO Margaret J. Mulligan, CFO Develops, manufactures, markets, licenses and distributes pharmaceutical products for the treatment of chronic medical conditions, including specialty and non-specialty central nervous system disorders, cardiovascular disease and pain management. Also generates revenue from third party pharmaceutical companies by promoting and/or co-promoting their products, by providing research development and clinical contract services, and through royalties and/or licensing fees related to the sale of a number of controlled-release products.
FP ADVISOR COVERAGE Biovail Corporation • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/BVF NYSE/BVF $14.79 $16.59 $10.90 US$0.36 US$0.09 2.6% 0.4 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 403,378 9.80 US$1.40 Sept. 30/09 11.3% -7.25% -0.74% $2,340,848
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08A 12m Dec. 31/07A 12m Dec. 31/06A US$000s US$000s US$000s Operating revenue 757,178 842,818 1,067,722 Net income 199,904 195,539 211,626 Total assets 1,623,565 1,782,115 2,192,442 US$ US$ US$ Earnings per share* 1.25 1.22 1.32 % % % Return on equity 16.00 15.04 16.07   * Common A Reported in accordance with U.S. GAAP
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09A Sept. 30/08A US$000s US$000s Operating revenue 760,873 779,578 Net income 223,835 47,553 US$ US$ Earnings per share 1.41 0.30   A Reported in accordance with U.S. GAAP

COMPANY NEWS

Results for 'Biovail Corporation' from past 30 days: 1 hit. Davis replaces Vaux as CFO at Loblaw National Post - Fri Jan 22 2010 - 93 words (Links are to articles.)